Ensuring Good Manufacturing Practices

It's no secret the Boston-Cambridge area is a hotbed for life sciences companies and the many vendors, suppliers, and contractors that service them. In fact, it's #1 on CBRE's list of the top life sciences clusters in the country according to Q3 2020 data.

As the life sciences industry is ever-evolving, manufacturers need to stay at the forefront with regards to new techniques and technology. One of the biggest booms in demand over the past decade has been for cell and gene therapies.

As many of you who work in the industry know, that means the need for specialized systems and high-tech equipment to produce these in-demand products. And with it, the need for expanded or brand new facilities.

While costs and schedules for facility builds and expansions can get out of hand, one way to streamline schedules and budgets is with integrated commissioning, qualification, and validation (CQV) strategies.

This white paper provides 10 CQV strategies cell and gene therapy manufacturing facilities can use to keep their build-outs on track.

Feel free to pass this along to your local life sciences colleagues and partners.